276 related articles for article (PubMed ID: 25587030)
21. Cell senescence, rapamycin and hyperfunction theory of aging.
Blagosklonny MV
Cell Cycle; 2022 Jul; 21(14):1456-1467. PubMed ID: 35358003
[TBL] [Abstract][Full Text] [Related]
22. Defects in p21WAF1/CIP1, Rb, and c-myc signaling in phorbol ester-resistant cancer cells.
Blagosklonny MV; Prabhu NS; El-Deiry WS
Cancer Res; 1997 Jan; 57(2):320-5. PubMed ID: 9000576
[TBL] [Abstract][Full Text] [Related]
23. mTOR inactivation by ROS-JNK-p53 pathway plays an essential role in psedolaric acid B induced autophagy-dependent senescence in murine fibrosarcoma L929 cells.
Qi M; Zhou H; Fan S; Li Z; Yao G; Tashiro S; Onodera S; Xia M; Ikejima T
Eur J Pharmacol; 2013 Sep; 715(1-3):76-88. PubMed ID: 23810968
[TBL] [Abstract][Full Text] [Related]
24. While reinforcing cell cycle arrest, rapamycin and Torins suppress senescence in UVA-irradiated fibroblasts.
Leontieva OV; Blagosklonny MV
Oncotarget; 2017 Dec; 8(65):109848-109856. PubMed ID: 29312653
[TBL] [Abstract][Full Text] [Related]
25. Inactive caspase 3 activates Akt in human leukemia cells susceptible or resistant to apoptosis induced by phorbol ester.
Hah JO; Lee KA; Choi YJ; Kim WD; Park JW; Kwon TK
Int J Oncol; 2003 May; 22(5):1111-6. PubMed ID: 12684678
[TBL] [Abstract][Full Text] [Related]
26. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
27. PKC-eta mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways.
Aeder SE; Martin PM; Soh JW; Hussaini IM
Oncogene; 2004 Dec; 23(56):9062-9. PubMed ID: 15489897
[TBL] [Abstract][Full Text] [Related]
28. PKCdelta and MAPK mediate G(1) arrest induced by PMA in SKBR-3 breast cancer cells.
Yokoyama G; Fujii T; Tayama K; Yamana H; Kuwano M; Shirouzu K
Biochem Biophys Res Commun; 2005 Feb; 327(3):720-6. PubMed ID: 15649406
[TBL] [Abstract][Full Text] [Related]
29. Hyper-mitogenic drive coexists with mitotic incompetence in senescent cells.
Leontieva OV; Lenzo F; Demidenko ZN; Blagosklonny MV
Cell Cycle; 2012 Dec; 11(24):4642-9. PubMed ID: 23187803
[TBL] [Abstract][Full Text] [Related]
30. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
31. Prolonged activation of the mitogen-activated protein kinase pathway is required for macrophage-like differentiation of a human myeloid leukemic cell line.
Hu X; Moscinski LC; Valkov NI; Fisher AB; Hill BJ; Zuckerman KS
Cell Growth Differ; 2000 Apr; 11(4):191-200. PubMed ID: 10775036
[TBL] [Abstract][Full Text] [Related]
32. Growth stimulation leads to cellular senescence when the cell cycle is blocked.
Demidenko ZN; Blagosklonny MV
Cell Cycle; 2008 Nov; 7(21):3355-61. PubMed ID: 18948731
[TBL] [Abstract][Full Text] [Related]
33. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells.
Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1601-26. PubMed ID: 25834400
[TBL] [Abstract][Full Text] [Related]
34. Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER(+), and HER2(-) Breast Cancer.
Yanai A; Inoue N; Yagi T; Nishimukai A; Miyagawa Y; Murase K; Imamura M; Enomoto Y; Takatsuka Y; Watanabe T; Hirota S; Sasa M; Katagiri T; Miyoshi Y
Clin Breast Cancer; 2015 Jun; 15(3):197-203. PubMed ID: 25600244
[TBL] [Abstract][Full Text] [Related]
35. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
36. DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence.
Leontieva OV; Blagosklonny MV
Aging (Albany NY); 2010 Dec; 2(12):924-35. PubMed ID: 21212465
[TBL] [Abstract][Full Text] [Related]
37. Gerosuppression by pan-mTOR inhibitors.
Leontieva OV; Blagosklonny MV
Aging (Albany NY); 2016 Dec; 8(12):3535-3551. PubMed ID: 28077803
[TBL] [Abstract][Full Text] [Related]
38. S6K1 is involved in polyploidization through its phosphorylation at Thr421/Ser424.
Ma D; Yu H; Lin D; Sun Y; Liu L; Liu Y; Dai B; Chen W; Cao J
J Cell Physiol; 2009 Apr; 219(1):31-44. PubMed ID: 19065636
[TBL] [Abstract][Full Text] [Related]
39. Induction of senescence in diterpene ester-treated melanoma cells via protein kinase C-dependent hyperactivation of the mitogen-activated protein kinase pathway.
Cozzi SJ; Parsons PG; Ogbourne SM; Pedley J; Boyle GM
Cancer Res; 2006 Oct; 66(20):10083-91. PubMed ID: 17047072
[TBL] [Abstract][Full Text] [Related]
40. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
Fang CX; Yang X; Sreejayan N; Ren J
Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
